Autonomy Capital (Jersey)’s Moderna MRNA Stock Holding History

Autonomy Capital (Jersey)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$8.55M	Buy	86,018 +5,410	+7%	+$455K	15.61%	1
2023 Q3	$8.33M	Buy	80,608 +12,413	+18%	+$1.38M	19.8%	1
2023 Q2	$8.29M	Buy	68,195 +78	+0.1%	+$10.4K	7.57%	4
2023 Q1	$10.5M	Buy	68,117 +2,040	+3%	+$337K	14.91%	2
2022 Q4	$11.9M	Sell	66,077 -3,512	-5%	-$574K	19.48%	1
2022 Q3	$8.23M	Buy	69,589 +36,027	+107%	+$5.47M	3.39%	2
2022 Q2	$4.79M	Buy	33,562 +31,090	+1,258%	+$4.44M	22.69%	1
2022 Q1	$426K	Buy	+2,472	New	+$416K	1.07%	13

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Autonomy Capital (Jersey)'s MRNA Position: Q4 2023 in Review

Autonomy Capital (Jersey) increased its Moderna (MRNA) stake by 6.7% in Q4 2023, buying an estimated $455K and bringing the position to 86,018 shares worth $8.55M. The position accounts for 15.61% of the portfolio, ranked #1.

Autonomy Capital (Jersey) first reported a position in MRNA in Q1 2022 and has held it in 8 quarters since. The position peaked at $11.9M in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

Autonomy Capital (Jersey) held 86,018 shares of Moderna worth $8.55M as of Q4 2023.
Autonomy Capital (Jersey) bought 5,410 Moderna shares in Q4 2023, an estimated $455K.
Moderna made up 15.61% of Autonomy Capital (Jersey)'s portfolio in Q4 2023, its #1 holding.
Autonomy Capital (Jersey) first reported a position in Moderna in Q1 2022 and has held it in 8 quarters since.
Autonomy Capital (Jersey)'s Moderna position peaked at $11.9M in Q4 2022.
884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Autonomy Capital (Jersey)'s 13F filing for Q4 2023, filed 14 Feb 2024.